G. I. Hockings - Concepedia

Author

G. I. Hockings

Greenslopes Private Hospital

Also Known As

G I Hockings, G. Hockings, G. I. Hockings, G.I. Hockings, GI Hockings

Publications

275

Citations

H-Index

Concepts

All Affiliations

Greenslopes Private Hospital The University of Queensland

About

G. I. Hockings is an author at Greenslopes Private Hospital specializing in medicine, endocrinology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	173
2	Endocrinology	6	6	156
3	Social Sciences	2	2	23
4	Anesthesia	2	2	77
5	Nephrology	1	1	17

G. I. Hockings

Publications

220

Citations

H-Index

Page 1

	Year	Citations
Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. David J. Torpy, Jeffrey E. Grice, G. I. Hockings, The Journal of Clinical Endocrinology & Metabolism Naloxone-stimulated Hypothalamo-pituitary-adrenal AxisMolecular PharmacologyAnesthesiaApz InhibitionStress Hormone	1993	54
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. David J. Torpy, Jeffrey E. Grice, G. I. Hockings, The Journal of Clinical Endocrinology & Metabolism Avp InjectionAvp LevelsStress HormoneMedicineVasopressin-stimulated Adrenocorticotropin	1994	42
Interactions Between the Stimulated Hypothalamic‐Pituitary‐Adrenal Axis and Leptin in Humans E. J. Nye, SR Bornstein, Jeffrey E. Grice, Journal of Neuroendocrinology	2000	27
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation. G. I. Hockings, Jeffrey E. Grice, G. V. Crosbie, The Journal of Clinical Endocrinology & Metabolism Adrenal GlandAnesthesiaOther Healthy SubjectsStress HormoneMedicine	1993	23
The Insulin Hypoglycemia Test: Hypoglycemic Criteria and Reproducibility E. J. Nye, Jeffrey E. Grice, G. I. Hockings, Journal of Neuroendocrinology	2001	20
Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment. Alpha S. Yap, G. I. Hockings, Simon J. Fleming, PubMed Translational MedicineUrologyHemodialysisIntravenous AhprbpNew Bisphosphonate	1990	17
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy. Jeffrey E. Grice, R. V. Jackson, G. I. Hockings, The Journal of Clinical Endocrinology & Metabolism Adrenal GlandAdrenocorticotropin HyperresponseStress HormonePsychiatryCorticotropin-releasing Hormone-mediated Stimulus	1995	14
The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. David J. Torpy, Jeffrey E. Grice, G. I. Hockings, The Journal of Clinical Endocrinology & Metabolism Hpa Axis ActivityPsychopharmacologyPharmacotherapyNoradrenergic ControlSocial Sciences	1995	12
Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport. G. I. Hockings, Jeffrey E. Grice, G. V. Crosbie, The Journal of Clinical Endocrinology & Metabolism PharmacotherapyExperimental PharmacologySocial SciencesAdrenal GlandNeuroendocrine Mechanism	1993	11

Page 1